Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anatole Besarab

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Kidney Medicine|September 2, 2024
Hemodialysis Vascular Access: A Historical Perspective on Access Promotion, Barriers, and Lessons for the FutureAnatole Besarab, Stanley Frinak, Suresh Margassery, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 28, 2006
Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemiaNizar Attallah, Yahya Osman-Malik, Stan Frinak, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 26, 2006
Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremiaUday S Nori, Anup Manoharan, Jerry Yee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2002
Dynamic venous access pressure ratio test for hemodialysis access monitoringStanley Frinak, Gerard Zasuwa, Thomas Dunfee, et al.
Seminars in Dialysis|August 21, 2010
Automated intravascular access pressure surveillance reduces thrombosis ratesGerard Zasuwa, Stanley Frinak, Anatole Besarab, et al.
BMC Nephrology|July 21, 2014
Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort studyLenar Yessayan, Jerry Yee, Gary Zasuwa, et al.
Seminars in Dialysis|October 13, 2021
Development and validation of a risk score to prioritize patients for evaluation of access stenosisBrad C Astor, Kim Hirschman, John Kennedy, et al.
Kidney International|June 30, 2012
The normal HCT trial re-revisited: what were the actual findings?Anatole Besarab, W Kline Bolton, Allen R Nissenson, et al.
The Journal of Vascular Access|November 15, 2022
Association of risk stratification score with dialysis vascular access stenosisLalathaksha Kumbar, Brad C Astor, Anatole Besarab, et al.
Journal of Nephrology|June 9, 2007
Vascular mapping techniques: advantages and disadvantagesArif Asif, Pietro Ravani, Prabir Roy-Chaudhury, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Kidney Medicine|September 2, 2024
Hemodialysis Vascular Access: A Historical Perspective on Access Promotion, Barriers, and Lessons for the FutureAnatole Besarab, Stanley Frinak, Suresh Margassery, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 28, 2006
Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemiaNizar Attallah, Yahya Osman-Malik, Stan Frinak, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 26, 2006
Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremiaUday S Nori, Anup Manoharan, Jerry Yee, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2002
Dynamic venous access pressure ratio test for hemodialysis access monitoringStanley Frinak, Gerard Zasuwa, Thomas Dunfee, et al.
Seminars in Dialysis|August 21, 2010
Automated intravascular access pressure surveillance reduces thrombosis ratesGerard Zasuwa, Stanley Frinak, Anatole Besarab, et al.
BMC Nephrology|July 21, 2014
Iron repletion is associated with reduction in platelet counts in non-dialysis chronic kidney disease patients independent of erythropoiesis-stimulating agent use: a retrospective cohort studyLenar Yessayan, Jerry Yee, Gary Zasuwa, et al.
Seminars in Dialysis|October 13, 2021
Development and validation of a risk score to prioritize patients for evaluation of access stenosisBrad C Astor, Kim Hirschman, John Kennedy, et al.
Kidney International|June 30, 2012
The normal HCT trial re-revisited: what were the actual findings?Anatole Besarab, W Kline Bolton, Allen R Nissenson, et al.
The Journal of Vascular Access|November 15, 2022
Association of risk stratification score with dialysis vascular access stenosisLalathaksha Kumbar, Brad C Astor, Anatole Besarab, et al.
Journal of Nephrology|June 9, 2007
Vascular mapping techniques: advantages and disadvantagesArif Asif, Pietro Ravani, Prabir Roy-Chaudhury, et al.
Pageof 9